Studies have shown that the typical Wnt antagonist Dickkopf-1 (DKK1) is upregulated in the brains of patients with AD and in AD mouse models and that restoration or enhancement of Wnt signaling can protect cells and synapses from Aβ toxicity and improve AD pathology [116]. This evidence concerns the gene DKK1 and Alzheimer disease.